Asia Pacific GMP Cytokines Market Forecast to 2027 - COVID-19 Impact and Regional Analysis By Type (TNF, Interleukins, Growth Factors, Others); Application (Cell and Gene Therapy, Tissue- Engineered Products, Others), and Country
Market Introduction
Cytokines play a significant role in regulating innate and adaptive immunity, which enable cells of the immune system to communicate over short distances. The cytokine therapy to activate cancer patients' immune systems has been an essential parameter in the treatment. Moreover, some cytokines indirectly inhibit tumor growth by stimulating the cytotoxic activity of immune cells against tumor cells.
Market Overview and Dynamics
The Asia Pacific GMP cytokines market is expected to reach US$ 33.37 million by 2027 from US$ 17.27 million in 2019; it is estimated to grow at a CAGR of 8.6% from 2020 to 2027. The growth of the Asia Pacific GMP cytokines market is attributed to key driving factors, such as increase in acceptance of cytokines for cancer and autoimmune therapies and potential contribution in stem cell therapy. However, high cost associated with GMP cytokines therapy is expected to obstruct the growth of the market to a certain extent during the forecast period.
Key Market Segments
Based on type, the Asia Pacific GMP cytokines market is segmented into TNF, interleukins, growth factors, and others. The growth factors segment held the largest share of the market in 2019, whereas, the TNF segment is expected to register the highest CAGR in the market during the forecast period.
In terms of application, the Asia Pacific GMP cytokines market is categorized into cell and gene therapy, tissue-engineered products, and others. The cell and gene therapy segment held the largest share of the market in 2019; however, the tissue-engineered products segment is anticipated to register the highest CAGR in the market during the forecast period.
Major Sources and Companies Listed
A Few of the primary and secondary sources associated with this report on the Asia Pacific gmp cytokines market are the Japanese Society of Interferon and Cytokine Research (JSICR), International Stem Cell Corporation (ISCO) and Centers for Disease Control and Prevention (CDC).
Reasons to buy the report
- Determine prospective investment areas based on a detailed trend analysis of the Asia Pacificgmp cytokines market over the next years.
- Gain an in-depth understanding of the underlying factors driving demand for different addictions therapeutics segments in the top spending countries and identify the opportunities offered by each of them.
- Strengthen your knowledge of the market in terms of demand drivers, industry trends, and the latest technological developments, among others.
- Identify the major channels driving the Asia Pacificgmp cytokines market, providing a clear picture of future opportunities that will help Analyze, resulting in revenue expansion.
- Channelize resources by focusing on the ongoing programs undertaken by the different countries within theAsia Pacificgmp cytokines market.
ASIA PACIFICGMP CYTOKINES SEGMENTATION
By Application
- Cell and Gene Therapy
- Tissue-Engineered Products
- Others
By Country
- China
- Japan
- India
- Australia
- South Korea
- Rest of Asia Pacific
Company Profiles
- Miltenyi Biotec
- Sino Biological Inc.
- ABCAM
- PeproTech, Inc.
- Akron Biotech
- BIO-TECHNE CORPORATION
- CREATIVE BIOARRAY
- Proteintech Group, Inc.
- REPROCELL, Inc.
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Asia Pacific GMP Cytokines Market – By Type
1.3.2 Asia Pacific GMP Cytokines Market – By Application
1.3.3 Asia Pacific GMP Cytokines market – By Country
2. GMP Cytokines Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Asia Pacific GMP Cytokines – Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 Asia Pacific – PEST Analysis
4.3 Expert Opinions
5. GMP Cytokines Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Growing Acceptance of Cytokines for Cancer and Autoimmune Therapies
5.1.2 Potential Contribution in Stem Cell Therapy
5.2 Market Restraints
5.2.1 High Cost Associated with GMP Cytokines Therapy
5.3 Market Opportunities
5.3.1 Extensive Pipeline of Drug Candidates for Cytokines Therapeutics
5.4 Future Trends
5.4.1 Utilization of Cytokines as Biomarkers
5.5 Impact Analysis
6. GMP Cytokines Market – Asia Pacific Analysis
6.1 Asia Pacific GMP Cytokines Market Revenue Forecast and Analysis
7. GMP Cytokines Market Analysis – By Type
7.1 Overview
7.2 GMP Cytokines Market Revenue Share, by Type (2019 and 2027)
7.3 TNF
7.3.1 Overview
7.3.2 TNF: GMP Cytokines Market – Revenue and Forecast to 2027 (US$ Million)
7.4 Interleukin
7.4.1 Overview
7.4.2 Interleukin: GMP Cytokines Market – Revenue and Forecast to 2027 (US$ Million)
7.5 Growth Factor
7.5.1 Overview
7.5.2 Growth Factor: GMP Cytokines Market – Revenue and Forecast to 2027 (US$ Million)
7.6 Others
7.6.1 Overview
7.6.2 Others: GMP Cytokines Market – Revenue and Forecast to 2027 (US$ Million)
8. GMP Cytokines Market Analysis – By Application
8.1 Overview
8.2 GMP Cytokines Market Revenue Share, by Application (2019 and 2027)
8.3 Celln and Gene Therapy
8.3.1 Overview
8.3.2 Cell and Gene Therapy: GMP Cytokines Market – Revenue and Forecast to 2027 (US$ Million)
8.4 Tissue-Engineered Products
8.4.1 Overview
8.4.2 Tissue-Engineered Products: GMP Cytokines Market – Revenue and Forecast to 2027 (US$ Million)
8.5 Others
8.5.1 Overview
8.5.2 Others: GMP Cytokines Market – Revenue and Forecast to 2027 (US$ Million)
9. GMP Cytokines Market – Asia Pacific Analysis
9.1 Asia Pacific: GMP Cytokines Market
9.1.1 Overview
9.1.2 Asia Pacific: GMP Cytokines Market - Revenue and Forecast to 2027 (USD Million)
9.1.3 Asia Pacific: GMP Cytokines Market, by Type, 2018–2027 (USD Million)
9.1.4 Asia Pacific: GMP Cytokines Market, by Application, 2018–2027 (USD Million)
9.1.5 Asia Pacific GMP Cytokines Market Revenue and Forecasts to 2027, By Country (%)
9.1.6 China: GMP Cytokines Market – Revenue and Forecast to 2027 (USD Million)
9.1.6.1 China: GMP Cytokines Market – Revenue and Forecast to 2027 (USD Million)
9.1.6.2 China: GMP Cytokines Market, by Type, 2018–2027 (USD Million)
9.1.6.3 China: GMP Cytokines Market, by Application, 2018–2027 (USD Million)
9.1.7 Japan: GMP Cytokines Market – Revenue and Forecast to 2027 (USD Million)
9.1.7.1 Japan: GMP Cytokines Market – Revenue and Forecast to 2027 (USD Million)
9.1.7.2 Japan: GMP Cytokines Market, by Type, 2018–2027 (USD Million)
9.1.7.3 Japan: GMP Cytokines Market, by Application, 2018–2027 (USD Million)
9.1.8 India: GMP Cytokines Market – Revenue and Forecast to 2027 (USD Million)
9.1.8.1 India: GMP Cytokines Market – Revenue and Forecast to 2027 (USD Million)
9.1.8.2 India: GMP Cytokines Market, by Type, 2018–2027 (USD Million)
9.1.8.3 India: GMP Cytokines Market, by Application, 2018–2027 (USD Million)
9.1.9 South Korea: GMP Cytokines Market – Revenue and Forecast to 2027 (USD Million)
9.1.9.1 South Korea: GMP Cytokines Market – Revenue and Forecast to 2027 (USD Million)
9.1.9.2 South Korea: GMP Cytokines Market, by Type, 2018–2027 (USD Million)
9.1.9.3 South Korea: GMP Cytokines Market, by Application, 2018–2027 (USD Million)
9.1.10 Australia: GMP Cytokines Market – Revenue and Forecast to 2027 (USD Million)
9.1.10.1 Australia: GMP Cytokines Market – Revenue and Forecast to 2027 (USD Million)
9.1.10.2 Australia: GMP Cytokines Market, by Type, 2018–2027 (USD Million)
9.1.10.3 Australia: GMP Cytokines Market, by Application, 2018–2027 (USD Million)
9.1.11 Rest of Asia Pacific: GMP Cytokines Market – Revenue and Forecast to 2027 (USD Million)
9.1.11.1 Rest of Asia Pacific: GMP Cytokines Market – Revenue and Forecast to 2027 (USD Million)
9.1.11.2 Rest of Asia Pacific: GMP Cytokines Market, by Type, 2018–2027 (USD Million)
9.1.11.3 Rest of Asia Pacific: GMP Cytokines Market, by Application, 2018–2027 (USD Million)
10. Impact of COVID-19 Pandemic on Asia Pacific GMP Cytokines Market
10.1 Asia-Pacific: Impact Assessment of COVID-19 Pandemic
11. Company Profiles
11.1 Miltenyi Biotec
11.1.1 Key Facts
11.1.2 Business Description
11.1.3 Products and Services
11.1.4 Financial Overview
11.1.5 SWOT Analysis
11.1.6 Key Developments
11.2 Sino Biological Inc.
11.2.1 Key Facts
11.2.2 Business Description
11.2.3 Products and Services
11.2.4 Financial Overview
11.2.5 SWOT Analysis
11.2.6 Key Developments
11.3 ABCAM
11.3.1 Key Facts
11.3.2 Business Description
11.3.3 Products and Services
11.3.4 Financial Overview
11.3.5 SWOT Analysis
11.3.6 Key Developments
11.4 PeproTech, Inc.
11.4.1 Key Facts
11.4.2 Business Description
11.4.3 Products and Services
11.4.4 Financial Overview
11.4.5 SWOT Analysis
11.4.6 Key Developments
11.5 Akron Biotech
11.5.1 Key Facts
11.5.2 Business Description
11.5.3 Products and Services
11.5.4 Financial Overview
11.5.5 SWOT Analysis
11.5.6 Key Developments
11.6 BIO-TECHNE CORPORATION
11.6.1 Key Facts
11.6.2 Business Description
11.6.3 Products and Services
11.6.4 Financial Overview
11.6.5 SWOT Analysis
11.6.6 Key Developments
11.7 CREATIVE BIOARRAY
11.7.1 Key Facts
11.7.2 Business Description
11.7.3 Products and Services
11.7.4 Financial Overview
11.7.5 SWOT Analysis
11.7.6 Key Developments
11.8 Proteintech Group, Inc.
11.8.1 Key Facts
11.8.2 Business Description
11.8.3 Products and Services
11.8.4 Financial Overview
11.8.5 SWOT Analysis
11.8.6 Key Developments
11.9 REPROCELL, Inc.
11.9.1 Key Facts
11.9.2 Business Description
11.9.3 Products and Services
11.9.4 Financial Overview
11.9.5 SWOT Analysis
11.9.6 Key Developments
12. Appendix
12.1 About the Insight Partners
12.2 Glossary of Terms
LIST OF TABLES
Table 1. Asia Pacific GMP Cytokines Market, by Type– Revenue and Forecast to 2027 (USD Million)
Table 2. Asia Pacific GMP Cytokines Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 3. China GMP Cytokines Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 4. China GMP Cytokines Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 5. Japan GMP Cytokines Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 6. Japan GMP Cytokines Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 7. India GMP Cytokines Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 8. India GMP Cytokines Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 9. South Korea GMP Cytokines Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 10. South Korea GMP Cytokines Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 11. Australia GMP Cytokines Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 12. Australia GMP Cytokines Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 13. Rest of Asia Pacific GMP Cytokines Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 14. Rest of Asia Pacific GMP Cytokines Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 15. Glossary of Terms, GMP Cytokines Market
LIST OF FIGURES
Figure 1. GMP Cytokines Market Segmentation
Figure 2. GMP Cytokines Market Segmentation, By Country
Figure 3. GMP Cytokines Market Overview
Figure 4. TNF Segment by Type Segment Expected to Witness Rapid Growth
Figure 5. Asia Pacific GMP Cytokines Market – Leading Country Markets (US$ Million)
Figure 6. Asia Pacific PEST Analysis
Figure 7. GMP Cytokines Market Impact Analysis of Drivers and Restraints
Figure 8. Asia Pacific GMP Cytokines Market – Revenue Forecast and Analysis – 2019- 2027
Figure 9. GMP Cytokines Market Revenue Share, by Type (2019 and 2027)
Figure 10. TNF: GMP Cytokines Market – Revenue and Forecast to 2027 (US$ Million)
Figure 11. Interleukin: GMP Cytokines Market – Revenue and Forecast to 2027 (US$ Million)
Figure 12. Growth Factor: GMP Cytokines Market – Revenue and Forecast to 2027 (US$ Million)
Figure 13. Others: GMP Cytokines Market – Revenue and Forecast to 2027 (US$ Million)
Figure 14. GMP Cytokines Market Revenue Share, by Application (2019 and 2027)
Figure 15. Cell and Gene Therapy: GMP Cytokines Market – Revenue and Forecast to 2027 (US$ Million)
Figure 16. Tissue-Engineered Products: GMP Cytokines Market – Revenue and Forecast to 2027 (US$ Million)
Figure 17. Others: GMP Cytokines Market – Revenue and Forecast to 2027 (US$ Million)
Figure 18. Asia Pacific: GMP Cytokines Market, by Key Country – Revenue (2019) (USD Million)
Figure 19. Asia Pacific GMP Cytokines Market Revenue and Forecast to 2027 (USD Million)
Figure 20. Asia Pacific: GMP Cytokines Market, by Country, 2019& 2027 (%)
Figure 21. China: GMP Cytokines Market – Revenue and Forecast to 2027 (USD Million)
Figure 22. Japan: GMP Cytokines Market – Revenue and Forecast to 2027 (USD Million)
Figure 23. India: GMP Cytokines Market – Revenue and Forecast to 2027 (USD Million)
Figure 24. South Korea: GMP Cytokines Market – Revenue and Forecast to 2027 (USD Million)
Figure 25. Australia: GMP Cytokines Market – Revenue and Forecast to 2027 (USD Million)
Figure 26. Rest of Asia Pacific: GMP Cytokines Market – Revenue and Forecast to 2027 (USD Million)
Figure 27. Impact of COVID-19 Pandemic in Asia Pacific Country Markets
- Miltenyi Biotec
- Sino Biological Inc.
- ABCAM
- PeproTech, Inc.
- Akron Biotech
- BIO-TECHNE CORPORATION
- CREATIVE BIOARRAY
- Proteintech Group, Inc.
- REPROCELL, Inc.
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the Asia PacificGMP cytokines market.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in the Asia PacificGMP cytokines market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth market trends and outlook coupled with the factors driving the market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.